tenk.fyi

C4 Therapeutics, Inc.

CCCCNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$35.9M

1.0% YoY

Net Income

-$105.0M

0.3% YoY

EPS

$-1.27

16.4% YoY

Cash

$74.6M

34.4% YoY

FY 2025 · As of 2025-12-31

No recent insider transactions found.

ProShowing last 90 days. Full 12+ month history available on Pro.
Upgrade